Back

Desmoglein 2 mutant mice reproduce arrhythmogenic right ventricular cardiomyopathy patients' phenotype

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Pathophysiological mechanisms in cardiomyopathies and hypertrophic remodeling Arrhythmias ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Seiko Ohno

National Cerebral & Cardiovascular Center, Suita (Japan)

4 More presentations in this session

Presentation thumbnail
Increased Tenascin-C expression contributes to cardiac dysfunction and fibrosis in Duchenne muscular dystrophy
Associate Professor A. Kiss (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
NAV3 is a genetic determinant of myocardial recovery in dilated cardiomyopathy and attenuates cardiac fibrosis
Doctor N. Pereira (Rochester, US)
Abstract Slides Video
Presentation thumbnail
The role of the atrium in the development of the Takotsubo Syndrome - investigation of a patient-specific atrial stem cell model
Doctor K. Streckfuss-Boemeke (Wuerzburg, DE)
Abstract Slides Video
Presentation thumbnail
Dysferlin facilitates the de novo biogenesis of tubular membranes in hypertrophic remodelling
Ms N. Paulke (Goettingen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Pathophysiological mechanisms in cardiomyopathies and hypertrophic remodeling

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Homozygous or compound heterozygous variants in DSG2 are mainly causative of Japanese arrhythmogenic right ventricular cardiomyopathy.
thumbnail
Congress Presentation
Unraveling the enigma of DSG2 p.(N266S): a culprit in arrhythmogenic cardiomyopathy
thumbnail
Congress Presentation
Prognostic role of the progression of late gadolinium enhancement in hypertrophic cardiomyopathy.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources